Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion
ES Daar, J Bai, MA Hausner… - Annals of internal …, 1998 - acpjournals.org
ES Daar, J Bai, MA Hausner, M Majchrowicz, M Tamaddon, JV Giorgi
Annals of internal medicine, 1998•acpjournals.orgMethods Antibodies to HIV were measured by enzyme immunoassay (Abbott Laboratories,
North Chicago, Illinois) and Western blot (Genetic Systems, Seattle, Washington). Plasma
HIV RNA was quantified by a branched-DNA assay (version 2.0, Chiron Diagnostics,
Emeryville, California), which measured as few as 500 copies/mL. Quantitative cultures of
plasma and peripheral blood mononuclear cells [1, 10] and memory cytotoxic T-lymphocyte
assays [11] were performed as described elsewhere.
North Chicago, Illinois) and Western blot (Genetic Systems, Seattle, Washington). Plasma
HIV RNA was quantified by a branched-DNA assay (version 2.0, Chiron Diagnostics,
Emeryville, California), which measured as few as 500 copies/mL. Quantitative cultures of
plasma and peripheral blood mononuclear cells [1, 10] and memory cytotoxic T-lymphocyte
assays [11] were performed as described elsewhere.
Methods
Antibodies to HIV were measured by enzyme immunoassay (Abbott Laboratories, North Chicago, Illinois) and Western blot (Genetic Systems, Seattle, Washington). Plasma HIV RNA was quantified by a branched-DNA assay (version 2.0, Chiron Diagnostics, Emeryville, California), which measured as few as 500 copies/mL. Quantitative cultures of plasma and peripheral blood mononuclear cells [1, 10] and memory cytotoxic T-lymphocyte assays [11] were performed as described elsewhere.
acpjournals.org